Related Experiment Videos
Designing accelerator-based epithermal neutron beams for boron neutron capture therapy
D L Bleuel1, R J Donahue, B A Ludewigt
1E. O. Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA. DLBleuel@lbl.gov
Medical Physics
|October 17, 1998
Summary
Accelerator-driven neutron sources using lithium-7 fluoride moderators show promise for Boron Neutron Capture Therapy (BNCT). These sources offer superior depth-dose distributions compared to existing reactor designs, potentially improving brain tumor treatments.
Area of Science:
- Nuclear Physics
- Medical Physics
- Radiation Oncology
Background:
- The 7Li(p,n)7Be reaction is explored as a potential accelerator-driven neutron source.
- Boron Neutron Capture Therapy (BNCT) requires specific neutron energy spectra for effective treatment.
Purpose of the Study:
- To evaluate accelerator-based neutron sources for BNCT.
- To analyze epithermal neutron beams shaped by different moderator materials.
- To compare dose distributions with existing reactor-based neutron sources.
Main Methods:
- Simulated radiation transport using the Monte Carlo N-particle (MCNP) code.
- Calculated fluence and dose distributions in a head phantom using BNCT treatment planning software.
- Investigated proton beam energy and moderator thickness effects on depth-dose distributions and treatment times.
Main Results:
- Al/AlF3 and 7LiF moderators produced superior depth-dose distributions compared to a reactor-based neutron beam.
- Achieved up to 50% higher doses near the midline of the brain.
- Estimated treatment time of approximately 40 minutes with a 20 mA proton beam and 7LiF moderator, delivering 21 Gy-Eq at 8 cm depth.
Conclusions:
- Accelerator-based neutron sources with Al/AlF3 or 7LiF moderators are effective for BNCT.
- These sources offer improved dose delivery for brain tumor treatments.
- The proposed system demonstrates feasibility for clinical BNCT applications.